Spirolactone provides protection from renal fibrosis by inhibiting the endothelial–mesenchymal transition in isoprenaline-induced heart failure in rats

References

• RoncoCCicoiraMMcCulloughPACardiorenal syndrome type 1 pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failureJ Am Coll Cardiol2012601031104222840531
   PubMed Web of Science ®Google Scholar
• GibsonCMPintoDSMurphySAAssociation of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortalityJ Am Coll Cardiol2003421535154314607434
   PubMed Web of Science ®Google Scholar
• CreemersEEPintoYMMolecular mechanisms that control interstitial fibrosis in the pressure-overloaded heartCardiovasc Res20118926527220880837
   PubMed Web of Science ®Google Scholar
• HeJXuYKoyaDKanasakiKRole of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney diseaseClin Exp Nephrol20131748849723430391
   PubMed Web of Science ®Google Scholar
• Piera-VelazquezSLiZJimenezSARole of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disordersAm J Pathol20111791074108021763673
   PubMed Web of Science ®Google Scholar
• RiederFKesslerSPWestGAInflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosisAm J Pathol20111792660267321945322
   PubMed Web of Science ®Google Scholar
• ZeisbergEMPotentaSESugimotoHFibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymaltransitionJ Am Soc Nephrol2008192282228718987304
   PubMed Web of Science ®Google Scholar
• LiJQuXBertramJFEndothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic miceAm J Pathol20091751380138819729486
   PubMed Web of Science ®Google Scholar
• MediciDShoreEMLounevVYConversion of vascular endothelial cells into multipotent stem-like cellsNat Med2010161400140621102460
   PubMed Web of Science ®Google Scholar
• NamsolleckPUngerTAldosterone synthase inhibitors in cardiovascular and renal diseasesNephrol Dial Transplant201429i62i6824493871
   PubMed Web of Science ®Google Scholar
• LuoJHGaoXPengLSunHDaiGEffects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failureEur J Pharmacol201166731432121703256
   PubMed Web of Science ®Google Scholar
• VardenyOCavallariLHClaggettBRace influences the safety and efficacy of spironolactone in severe heart failureCirc Heart Fail2013697097623940307
   PubMed Web of Science ®Google Scholar
• EdwardsNCSteedsRPChueCDThe safety and tolerability of spironolactone in patients with mild to moderate chronic kidney diseaseBr J Clin Pharmacol20127344745421950312
   PubMed Web of Science ®Google Scholar
• HillegeHLvan GilstWHvan VeldhuisenDJAccelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trialEur Heart J20032441242012633543
   PubMed Web of Science ®Google Scholar
• ParikhCRCocaSGWangYLong term prognosis of acute kidney injury after acute myocardial infarctionArch Intern Med200816898799518474763
   PubMedGoogle Scholar
• SigurdssonAHeldPSwedbergKShort- and long-term neurohormonal activation following acute myocardial infarctionAm Heart J1993126106810768237747
   PubMed Web of Science ®Google Scholar
• LeaskATGFbeta, cardiac fibroblasts, and the fibrotic responseCardiovasc Res20077420721216919613
   PubMed Web of Science ®Google Scholar
• WolfGRenal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathwayKidney Int2006701914191916985515
   PubMed Web of Science ®Google Scholar
• Akiyama-UchidaYAshizawaNOhtsuruANorepinephrine enhances fibrosis mediated by TGF-beta in cardiac fibroblastsHypertension20024014815412154105
   PubMed Web of Science ®Google Scholar
• BergerRPacherRThe role of the endothelin system in myocardial infarction – new therapeutic targets?Eur Heart J20032429429612581675
   PubMedGoogle Scholar
• TakedaYNishikimiTAkimotoKMatsuokaHIshimitsuTBeneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstructionHypertens Res20103396597320664550
   PubMed Web of Science ®Google Scholar
• ZojaCCornaDGagliardiniEAdding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotectionAm J Physiol Renal Physiol2010299F1203F121120719975
   PubMed Web of Science ®Google Scholar
• StruthersAKrumHWilliamsGHA comparison of the aldosterone-blocking agents eplerenone and spironolactoneClin Cardiol20083115315818404673
   PubMed Web of Science ®Google Scholar
• MicheaLVillagránAUrzúaAMineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic ratsHypertension20085229530018591458
   PubMed Web of Science ®Google Scholar
• EddyAAExperimental insights into the tubulointerstitial disease accompanying primary glomerular lesionsJ Am Soc Nephrol19945127312877893992
   PubMed Web of Science ®Google Scholar
• EddyAAMolecular basis of renal fibrosisPediatr Nephrol20001529030111149129
   PubMed Web of Science ®Google Scholar
• MarneyAMBrownNJAldosterone and end-organ damageClin Sci (Lond)200711326727817683282
   PubMed Web of Science ®Google Scholar
• BoorPFloegeJThe renal (myo-)fibroblast: a heterogeneous group of cellsNephrol Dial Transplant2012273027303622851626
   PubMed Web of Science ®Google Scholar
• KrenningGZeisbergEMKalluriRThe origin of fibroblasts and mechanism of cardiac fibrosisJ Cell Physiol201022563163720635395
   PubMed Web of Science ®Google Scholar
• BarnesJLGlassWF2ndRenal interstitial fibrosis: a critical evaluation of the origin of myofibroblastsContrib Nephrol2011169739321252512
   PubMed Web of Science ®Google Scholar
• MarkwaldRRFizharrisTPSmithWNStructural analysis of endocardial cytodifferentiationDev Biol19751421601801112439
   PubMedGoogle Scholar
• Mercado-PimentelMERunyanRBMultiple transforming growth factor-beta isoforms and receptors function during epithelial- mesenchymal cell transformation in the embryonic heartCells Tissues Organs200718514615617587820
   PubMed Web of Science ®Google Scholar
• KisanukiYYHammerREMiyazakiJTie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivoDev Biol200123023024211161575
   PubMed Web of Science ®Google Scholar
• GuneyISelcukNYAltintepeLAntifibrotic effects of aldosterone receptor blocker (spironolactone) in patients with chronic kidney diseaseRen Fail20093177938419925284
   PubMed Web of Science ®Google Scholar
• VerrecchiaFMauvielATransforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulationJ Invest Dermatol200211821121511841535
   PubMed Web of Science ®Google Scholar
• ZhouXChenXCaiJJRelaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathwayDrug Des Devel Ther20151145994611
   Web of Science ®Google Scholar